Eskayef Pharmaceuticals Limited, one of the leading pharmaceutical companies of Bangladesh, has been accredited once again with the prestigious US Food and Drug Administration (US FDA) approval for its third manufacturing unit located at Tongi, Gazipur.The company received the approval very recently for its sterile manufacturing unit of Faraaz Ayaaz Hossain Building from the most stringent regulatory authority in the world, the company said in a statement.Eskayef is the only pharmaceutical company in the country to have injectable manufacturing units approved by the US .....
Eskayef Pharmaceuticals Limited, one of the leading pharmaceutical companies of Bangladesh, started exporting complex injectable products to the most coveted market in the world, USA.It is the first time an injectable product from Bangladesh is being shipped to USA, according to a press release issued by Eskayef.
Earlier in September 2022, Eskayef was accredited with the prestigious US FDA approval for its injectable manufacturing facility. It is the 1st and only injectable manufacturing site in Bangladesh to achieve such a stringent accreditation.Prior to that, .....
Eskayef Pharmaceuticals Limited, one of the leading pharmaceutical companies of Bangladesh, has been accredited with the prestigious US FDA approval for its injectable manufacturing facility.This is the first and only injectable manufacturing site in Bangladesh to achieve such a stringent accreditation, according to a press release issued by Eskayef Pharmaceuticals Limited.This approval will allow Eskayef to export injectable pharmaceutical products from the state-of-the-art facility to the US market. "It is a moment of great pride for .....
Transcom - Excellence and ethics sustain Bangladesh's
leading business house Bangladesh's economic track record is impressive, to say
the least, and over the past decade it has consistently been one of the world's
fastest-growing economies. Real GDP growth averaged 6.8% between 2010 and 2019,
supported by favorable demographics, a powerhouse manufacturing industry, and
stable macroeconomic conditions. The IMF projects GDP growth will hit 6.6% in
2022, and exceed pre-pandemic levels by 2023 to reach 7.1%. The country's
economic rebound will be one of the strongest and most sustained .....
Eskayef Pharmaceuticals, one of the country's top pharmaceutical companies, has set up Bangladesh's first manufacturing facility to produce insulin cartridges, a positive development for the millions of local diabetic patients.The state-of-the-art production plant was inaugurated yesterday aiming to start supplying the insulin penfills by the third quarter of next year following successful trials and approval from the Directorate General of Drug Administration (DGDA).
Eskayef Pharmaceuticals has set up the plant in its Tongi production site with technical cooperation from .....
Eskayef
Pharmaceuticals Limited, one of the leading pharmas of Bangladesh, has received
approval from the US Food and Drug Administration (FDA) for its solid
manufacturing facility of Faraaz Ayaaz Hossain Building (FAHB) located in
Tongi, Gazipur.
গাজীপুরের
টঙ্গীতে ফারাজ আয়াজ হোসেন ভবনে (এফএএইচবি) ওষুধ প্রস্তুতের সুবিধার জন্য যুক্তরাষ্ট্রের
খাদ্য ও ওষুধ প্রশাসনের (ইউএস এফডিএ) অনুমোদন পেয়েছে বাংলাদেশের অন্যতম শীর্ষ
ওষুধ কোম্পানি এসকেএফ ফার্মাসিউটিক্যালস .....
Corona oral medication reduces the risk of hospitalization and death of Paxovir patients by 89 percent, experts said. They say that if the drug is given early in corona patients with mild to moderate symptoms, the severity of the virus infection will decrease.
However, caution is needed in determining the dosage and use of Paxovir. The drug can be a ‘game changer’ in the treatment of corona patients.
This was stated by eminent physicians of the country, senior officials of the government's health department and public health experts while participating in the CME .....
The new Paxovir will be a game changer in treating Covid-19 patients with mild to moderate symptoms as it reduces the need for hospitalisation and risk of death by almost 89 percent, said speakers at a scientific seminar yesterday.But physicians must ensure proper use of the oral antiviral drug to get the best outcome, they added.Renowned physicians of 42 medical institutions from Bangladesh and 30 other countries participated at the discussion titled "An Update on Antivirals for Covid-19".They also lauded Eskayef Pharmaceuticals Ltd for the fast-pace introduction of .....
Eskayef Pharmaceuticals Limited, one of the leading drug manufacturing companies of Bangladesh, has received emergency use authorisation for a novel oral antiviral medicine for the treatment of Covid-19 -- world's 1st generic version of Nirmatrelvir tablets co-packaged with Ritonavir tablets -- with the brand name "Paxovir".
The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for Nirmatrelvir tablets and Ritonavir tablets, co-packaged for oral use for the treatment of mild-to-moderate Covid-19 in adults and paediatric patients over 12 years of age. .....
Eskayef Pharmaceuticals Limited, one of the leading drug manufacturing companies of
Bangladesh has launched world’s 1st Approved Oral Anti-COVID medicine Molnupiravir with the
brand name Monuvir in the form of 200mg capsule. Monuvir is now available in different hospitals,
institutions and drug stores all over Bangladesh to be dispensed as per doctor’s prescription.
World’s one of the stringent drug regulatory authorities, UK MHRA authorizes Molnupiravir as the first
oral antiviral for the treatment of COVID-19. Eskayef is manufacturing Molnupiravir from its UK .....
Eskayef Pharmaceuticals yesterday rolled out the world's first oral anti-Covid drug Molnupiravir after the drug administration gave emergency production and marketing authorisation of the pill that is said to halve the rate of hospitalisations and deaths in high-risk Covid-19 patients.
Called Monuvir, the tablet, which costs Tk 50, is available in all drug stores and hospitals all over the country, according to Mohammad Mujahidul Islam, executive director of Eskayef's marketing and sales.Developed by American pharmaceuticals companies Merck and Ridgeback Biotherapeutics, the .....
The oncology manufacturing facility of Eskayef Pharmaceuticals, one of the finest medicine manufacturing companies in Bangladesh, has obtained the approval of European Union Good Manufacturing Practice (EU GMP) for maintaining its standard in production of oncology drugs.
As a result, the people of Bangladesh can now get world class medicines in the country to treatment cancer patients.
Eskayef Pharmaceuticals is the first ever Bangladeshi company to get the approval of EU GMP, a highly prestigious standard that a medicines manufacturer must meet in their production processes. The .....
Source: Moneycontrolhttps://cutt.ly/DUZKVX7Eskayef Pharma had been quick to take advantage of international trade rules that allow nations defined by the United Nations as least-developed countries to ignore patents and produce affordable drugs.The Maharashtra government's decision to import Gilead's antiviral drug Remdesivir from Bangladesh drug maker Eskayef Pharmaceuticals has taken the Indian pharmaceutical industry by surprise.
But analysts and legal experts pointed out that it is perfectly legal to import the drug if .....
Source: Prothom Alohttps://cutt.ly/dUZK8ECEskayef Pharmaceuticals, one of the leading drug manufacturing companies of the country, has successfully produced remdesivir, the drug used to treat coronavirus. All procedures for production have been completed and preparations have begun from Friday morning for distribution of the drug.
Managing director and chief executive officer of Eskayef, Simeen Hossain, speaking to Prothom Alo, said at this crucial time in the country, we are happy to give the people the good news that we have .....
A Bangladeshi company says it has produced the first generic version of the anti-viral drug remdesivir, which is currently being tested as a possible treatment for COVID-19.
"We have successfully completed all the steps in the manufacturing of remdesivir," Simeen Hossain, head of Eskayef Pharmaceuticals Bangladesh Limited, said on Friday about the production of the drug developed and patented by Gilead Sciences in the US.
The announcement comes as Gilead negotiates with pharmaceutical manufacturers in India and Pakistan over the production of remdesivir for developing .....
Source: The Daily Starhttps://cutt.ly/EUZHsnWEskayef Pharmaceuticals, one of the leading drug manufacturing companies of the country, has successfully produced Remdesivir, the drug used to treat coronavirus. All procedures for production have been completed and preparations have begun from Friday (today) morning for distribution of the drug.
Managing Director and Chief Executive Officer of Eskayef, Simeen Hossain, speaking to The Daily Star, said at this crucial time in the country, we are happy to give the people the good news that .....
Eskayef Pharmaceuticals Limited has completed the production of Remdisivir, the drug which is proved to be effective in treating COVID-19 patients.
After completion of all production process, the company started to distribute the drug on Friday, according to a media statement.
Managing Director and Chief Executive Officer of Eskayef Simeen Hossain in a media statement said, we are glad to inform you that Remdesivir, the only effective drug against coronavirus, is now at our hands.
Remdesivir, a drug developed by Gilead .....
Novo Nordisk, the world's biggest insulin maker, yesterday launched three locally manufactured insulin products in Bangladesh.
The three products -- Mixtard 30, Insulatard and Actrapid -- all manufactured by the Danish company's local partner Eskayef Bangladesh Ltd, were unveiled at a ceremony at the Westin Hotel in the city.
With the launch, Novo Nordisk, which controls 75 percent of the local insulin market, and Eskayef, Bangladesh's one of the fastest growing medicine makers, will be able to take the insulin products to the patients at affordable prices.
This is the first time the .....
